In this issue, we present another installment of our quarterly review of dealmaking—for April-June 2005. Our data comes from Windhover's Strategic Intelligence Systems, which covers deal activity within the pharmaceutical/biotechnology, medical device and in vitro diagnostics industries.
Some notes about our coverage: we limit our review to human health care (thus no animal health or agricultural transactions)...